Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 6, 2003, Pages 405-413

  Linker, Charles ^a   Anderlini, Paolo ^b   Herzig, Roger ^c   Christiansen, Neal ^d   Somlo, George ^e   Bensinger, William ^f   Fay, Joseph ^g   Lynch, Joseph P ^h   Goodnough, Lawrence T ⁱ   Ashby, Mark ^j   Benyunes, Mark C ^j   Jones, Dennie V ^j   Yang, Timothy A ^j   Miller, Langdon L ^k   Weaver, Charles ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^h Natalie Warren Bryant Cancer Center   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j GENENTECH INC   (United States)

^k PFIZER INC   (United States)

^l Response Oncology Inc   (United States)

more..

Author keywords

Mobilization; Thrombopoietin

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; ANTICOAGULANT AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CD34 ANTIGEN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELPHALAN; MITOMYCIN C; NEUTRALIZING ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT THROMBOPOIETIN; THIOTEPA;

ADULT; AGED; ARTICLE; ASTHENIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE PAIN; BREAST CANCER; CANCER CHEMOTHERAPY; CEREBROVASCULAR ACCIDENT; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DYSPNEA; FEMALE; FEVER; HEADACHE; HEART ATRIUM FIBRILLATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE MYELOMA; MULTIPLE ORGAN FAILURE; NAUSEA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PHLEBITIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STEM CELL MOBILIZATION; THORAX PAIN; THROMBOCYTE; THROMBOCYTOSIS; THROMBOEMBOLISM; THROMBOPHLEBITIS; VEIN THROMBOSIS; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; THROMBOPOIETIN; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 12144289061     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00101-0     Document Type: Article

References (40)

1. McGuire W.P. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors Curr Probl Cancer 22 1998 135-177
2. San Miguel J.F. Blade C.J. Garcia-Sanz R. Treatment of multiple myeloma Haematologica 84 1999 36-58
3. Tallman M.S. Gradishar W.J. High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer Cancer Chemother Pharmacol 42Suppl 1998 S60-S67
4. Inoue R. Natazuka T. Shimoyama M. et al. Feasibility of high-dose chemotherapy without stem cell support as a first-line treatment for non-Hodgkin's aggressive lymphoma: a pilot study Leuk Lymphoma 36 2000 315-321
5. Nordic Myeloma Study Group Lenhoff S. Hjorth M. Holmberg E. et al. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study Blood 95 2000 7-11
6. Rajkumar S.V. Fonseca R. Lacy M.Q. et al. Autologous stem cell transplantation for relapsed and primary refractory myeloma Bone Marrow Transplant 23 1999 1267-1272
7. Nademanee A. Molina A. O'Donnell M.R. et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group Blood 90 1997 3844-3852
8. Demirer T. Buckner C.D. Bensinger W.I. Optimization of peripheral blood stem cell mobilization Stem Cells 14 1996 106-116
9. Klumpp T.R. Mangan K.F. Goldberg S.L. Pearlman E.S. Macdonald J.S. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial J Clin Oncol 13 1995 1323-1327
10. Stadtmauer E.A. Schneider C.J. Silberstein L.E. Peripheral blood progenitor cell generation and harvesting Semin Oncol 22 1995 291-300
11. Shpall E.J. Cagnoni P.J. Bearman S.I. Ross M. Jones R.B. Peripheral blood stem cells for autografting Annu Rev Med 48 1997 241-251
12. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 19 1997 303-310
13. + peripheral blood progenitor cell dose on hematopoietic recovery Biol Blood Marrow Transplant 4 1998 84-92
14. Bernstein S.H. Nademanee A.P. Vose J.M. et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation Blood 91 1998 3509-3517
15. Kaushansky K. Thrombopoietin: understanding and manipulating platelet production Annu Rev Med 48 1997 1-11
16. Cohen-Solal K. Debili N. Vainchenker W. Wendling F. Thrombopoietin (Mpl-ligand) and the regulation of platelet production Thromb Haemost 78 1997 37-41
17. Kaushansky K. The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development Stem Cells 12Suppl 1 1994 91-97
18. Wendling F. Maraskovsky E. Debili N. et al. cMpl ligand is a humoral regulator of megakaryocytopoiesis Nature 369 1994 571-574
19. Alexander W.S. Begley C.G. Thrombopoietin in vitro and in vivo Cytokines Cell Mol Ther 4 1998 25-34
20. Baatout S. Thrombopoietin. A review Haemostasis 27 1997 1-8
21. Wagemaker G. Hartong S.C. Neelis K.J. Egeland T. Wognum A.W. In vivo expansion of hemopoietic stem cells Stem Cells 16Suppl1 1998 185-191
22. Kaushansky K. Thrombopoietin N Engl J Med 339 1998 746-754
23. de Sauvage F.J. Hass P.E. Spencer S.D. et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand Nature 369 1994 533-538
24. Bartley T.D. Bogenberger J. Hunt P. et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl Cell 77 1994 1117-1124
25. Lok S. Kaushansky K. Holly R.D. et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo Nature 369 1994 565-568
26. Coleman D. Fairchild D. Schindler-Horvat J. Munyakazi L. Neumann T.A. Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression Toxicol Sci 45 1998 77-87
27. Wagemaker G. Neelis K.J. Hartong S.C. et al. The efficacy of recombinant thrombopoietin in murine and nonhuman primate models for radiation-induced myelosuppression and stem cell transplantation Stem Cells 16 1998 375-386
28. van de Ven C. Fernandez G.W. Herbst T. et al. The haemopoietic effects of thrombopoietin administered post-myelosuppressive carboplatin therapy compared to either pre- and post- or pre-chemotherapy Br J Haematol 102 1998 775-782
29. Vadhan-Raj S. Murray L.J. Bueso-Ramos C. et al. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer Ann Intern Med 126 1997 673-681
30. + cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis Exp Hematol 26 1998 207-216
31. Somlo G. Sniecinski I. ter Veer A. et al. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy Blood 93 1999 2798-2806
32. Gajewski J. Durett A. Korbling M. et al. Increased CD34 using single or multi-dose human thrombopoietic in addition to Neupogen for peripheral blood progenitor cell (PBPC) for mobilization Blood 92 1998 270a [abstract]
33. + selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer Blood 89 1997 1521-1528
34. Vadhan-Raj S. Recombinant human thrombopoietin: clinical experience and in vivo biology Semin Hematol 35 1998 261-268
35. Vadhan-Raj S. Patel S. Broxmeyer H. et al. Schedule-dependent reduction in thrombocytopenia by recombinant human thrombopoietin (rhTPO) in patients with sarcoma receiving high-dose chemotherapy (CT) with adriamycin (A) and ifosfamide (I) Proc Am Soc Clin Oncol 18 1999 52a [abstract 193]
36. Emmons R.V. Reid D.M. Cohen R.L. et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction Blood 87 1996 4068-4071
37. Meng Y.G. Martin T.G. Peterson M.L. TPO regulation following bone marrow transplantation [abstract 1237] Blood 86Suppl 1 1995 313a
38. + selected vs unselected autologous peripheral blood progenitor cell transplantation for patients with advanced multiple myeloma: engraftment resultts [abstract] Blood 90Suppl 1 1997 218a
39. Farese A.M. Hunt P. Boone T. MacVittie T.J. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates Blood 86 1995 54-59
40. Amgen. Amgen discontinues development of MGDF Available at: http://www.amgen.com/News/news98/pressRelease980911.htm (accessed Sept 11, 1998).